Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1, 4]oxazin-3(4H)-one and 2H-benzo[b][1, 4]oxazine scaffold derivatives as PI3Kα inhibitors. Issue 14 (7th August 2018)
- Record Type:
- Journal Article
- Title:
- Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1, 4]oxazin-3(4H)-one and 2H-benzo[b][1, 4]oxazine scaffold derivatives as PI3Kα inhibitors. Issue 14 (7th August 2018)
- Main Title:
- Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1, 4]oxazin-3(4H)-one and 2H-benzo[b][1, 4]oxazine scaffold derivatives as PI3Kα inhibitors
- Authors:
- Dong, Fu-Dan
Liu, Dan-Dan
Deng, Cheng-Long
Qin, Xiao-chun
Chen, Kai
Wang, Jian
Song, Hong-Rui
Ding, Huai-Wei - Abstract:
- Graphical abstract: Highlights: Two series of novel 2 H -benzo[ b ][1, 4]oxazin derivatives were synthesized and characterized. Their antiproliferative activities against cancer cell lines were evaluated. 7f exhibited PI3Kα inhibitory activity with an IC50 value of 26.7 nM. 7f exhibited potent antiproliferative effects via PI3K/Akt signaling pathway inhibition. Abstract: The abnormal activation of PI3K signaling pathway leads to the occurrence of various cancers. The PI3Kα is frequently mutated and overexpressed in many human cancers. Therefore, the PI3Kα was considered as a promising target in therapeutic treatment of cancer. In this study, two series of compounds containing 2 H -benzo[ b ][1, 4]oxazin-3(4 H )-one and 2 H -benzo[ b ][1, 4]oxazine scaffold were synthesized and evaluated antiproliferative activities against three cancer cell lines, including HCT-116, MDA-MB-231 and SNU638. Compound 7f with the most potent antiproliferative activity was selected for further evaluation on normal cells and PI3K kinase. Studies indicated that compound 7f could decrease the phospho-Akt (T308) in a dose-dependent manner. Four key hydrogen bonding interactions were found in the docking of 7f with PI3K enzyme. All the results suggested that 7f was a potent PI3Kα inhibitor.
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 26:Issue 14(2018)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 26:Issue 14(2018)
- Issue Display:
- Volume 26, Issue 14 (2018)
- Year:
- 2018
- Volume:
- 26
- Issue:
- 14
- Issue Sort Value:
- 2018-0026-0014-0000
- Page Start:
- 3982
- Page End:
- 3991
- Publication Date:
- 2018-08-07
- Subjects:
- PI3Kα, -- 2H-Benzo[b][1, 4]oxazin-3(4H)-one -- 2H-Benzo[b][1, 4]oxazine -- Anticancer
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2018.06.022 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20883.xml